BR0213408A - Métodos de prevenção e de tratamento de infecção por flavivìrus em animais - Google Patents

Métodos de prevenção e de tratamento de infecção por flavivìrus em animais

Info

Publication number
BR0213408A
BR0213408A BR0213408-0A BR0213408A BR0213408A BR 0213408 A BR0213408 A BR 0213408A BR 0213408 A BR0213408 A BR 0213408A BR 0213408 A BR0213408 A BR 0213408A
Authority
BR
Brazil
Prior art keywords
animals
methods
prevention
treatment
flavivirus infection
Prior art date
Application number
BR0213408-0A
Other languages
English (en)
Inventor
Thomas P Monath
Juan Arroyo
Original Assignee
Acambis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acambis Inc filed Critical Acambis Inc
Publication of BR0213408A publication Critical patent/BR0213408A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODOS DE PREVENçãO E DE TRATAMENTO DE INFECçãO POR FLAVIVìRUS EM ANIMAIS". A presente invenção refere-se a métodos de prevenção e de tratamento de infecção por flavivírus em animais.
BR0213408-0A 2001-10-19 2002-10-21 Métodos de prevenção e de tratamento de infecção por flavivìrus em animais BR0213408A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34684501P 2001-10-19 2001-10-19
PCT/US2002/033795 WO2003063725A2 (en) 2001-10-19 2002-10-21 Methods of preventing and treating flavivirus infection in animals

Publications (1)

Publication Number Publication Date
BR0213408A true BR0213408A (pt) 2004-11-03

Family

ID=27662959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213408-0A BR0213408A (pt) 2001-10-19 2002-10-21 Métodos de prevenção e de tratamento de infecção por flavivìrus em animais

Country Status (20)

Country Link
US (1) US6878372B2 (pt)
EP (1) EP1441761B1 (pt)
JP (2) JP5164305B2 (pt)
KR (3) KR101131579B1 (pt)
AT (1) ATE359816T1 (pt)
AU (1) AU2002365922B2 (pt)
BR (1) BR0213408A (pt)
CA (1) CA2464138C (pt)
CY (1) CY1107439T1 (pt)
DE (1) DE60219658T2 (pt)
DK (1) DK1441761T3 (pt)
ES (1) ES2284984T3 (pt)
IL (2) IL161501A0 (pt)
MX (1) MXPA04003692A (pt)
NZ (1) NZ532385A (pt)
PT (1) PT1441761E (pt)
RU (1) RU2313367C2 (pt)
SI (1) SI1441761T1 (pt)
WO (1) WO2003063725A2 (pt)
ZA (1) ZA200403047B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962708B1 (en) * 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
WO2002072036A2 (en) * 2001-03-12 2002-09-19 Yale University Compositions and methods comprising west nile virus polypeptides
CN1551782A (zh) * 2001-06-01 2004-12-01 ��������ķ������ 嵌合黄病毒载体
KR101074175B1 (ko) 2002-01-15 2011-10-14 사노피 파스테르 바이오로직스 씨오 플라비바이러스 백신
US20050002968A1 (en) * 2002-01-15 2005-01-06 Monath Thomas P. Flavivirus vaccines
WO2004045529A2 (en) 2002-11-15 2004-06-03 Acambis, Inc. West nile virus vaccine
CA2612047C (en) * 2005-06-24 2015-05-12 Intervet International B.V. Inactivated chimeric vaccines and related methods of use
CA2616026A1 (en) * 2005-07-22 2007-02-08 Research Development Foundation Attenuated strains of flaviviruses , and uses thereof
AU2009287449B2 (en) 2008-08-29 2015-04-30 Boehringer Ingelheim Animal Health USA Inc. West nile virus vaccine
WO2010085358A2 (en) * 2009-01-23 2010-07-29 The Board Of Regents Of The University Of Texas System Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
BR112013023354B1 (pt) 2011-03-14 2022-02-15 Boehringer Ingelheim Animal Health Usa Inc Composição imunogênica compreendendo cepas de vírus da rinite equina a (erav) e seu método de produção
KR101868554B1 (ko) 2016-10-18 2018-06-19 강원대학교산학협력단 브루셀라 어보투스 ba15 변이주 및 이를 포함하는 브루셀라병 예방용 백신 조성물
GB201716222D0 (en) * 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric Flavivirus Vaccines
CN113429479B (zh) * 2018-04-04 2023-03-10 中国科学院微生物研究所 一种高灵敏度的黄热病毒人源单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184024B1 (en) * 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
EP1018556B1 (en) * 1991-09-19 2005-11-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of HEALTH AND HUMAN SERVICES Chimeric and/or growth-restricted flaviviruses
EP0977587B1 (en) * 1997-02-28 2005-06-15 Acambis Inc. Chimeric flavivirus vaccines
AU1813901A (en) 1999-12-01 2001-06-12 Oravax, Inc Chimeric flavivirus vaccines

Also Published As

Publication number Publication date
ZA200403047B (en) 2005-06-29
US20030129201A1 (en) 2003-07-10
JP2005516974A (ja) 2005-06-09
CA2464138C (en) 2013-08-13
RU2004115107A (ru) 2005-04-20
IL161501A (en) 2010-05-17
IL161501A0 (en) 2004-09-27
ES2284984T3 (es) 2007-11-16
KR20100092038A (ko) 2010-08-19
DE60219658D1 (de) 2007-05-31
KR20040052245A (ko) 2004-06-22
EP1441761A2 (en) 2004-08-04
MXPA04003692A (es) 2005-04-08
DE60219658T2 (de) 2008-01-03
AU2002365922B2 (en) 2007-11-22
KR20120016315A (ko) 2012-02-23
NZ532385A (en) 2007-01-26
CA2464138A1 (en) 2003-08-07
EP1441761B1 (en) 2007-04-18
RU2313367C2 (ru) 2007-12-27
CY1107439T1 (el) 2012-12-19
JP5164305B2 (ja) 2013-03-21
EP1441761A4 (en) 2004-12-29
ATE359816T1 (de) 2007-05-15
JP2010215647A (ja) 2010-09-30
WO2003063725A3 (en) 2003-10-30
US6878372B2 (en) 2005-04-12
DK1441761T3 (da) 2007-08-27
SI1441761T1 (sl) 2007-08-31
PT1441761E (pt) 2007-07-16
KR101131579B1 (ko) 2012-03-30
WO2003063725A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
BR0213408A (pt) Métodos de prevenção e de tratamento de infecção por flavivìrus em animais
MXPA02011621A (es) Mimeticos de trombopoyetina.
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ATE315934T1 (de) Thrombopoietin-mimetika
GB0025173D0 (en) Therapeutic agents
ATE514430T1 (de) Behandlung des alpha-galactosidase a mangels
NZ517616A (en) Use of retigabin for treating neuropathic pain
DE60119784D1 (de) Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
BR9911094A (pt) Composições e métodos para o tratamento detosse
BR0211830A (pt) Dose única de azitromicina
HUP0401672A3 (en) Low concentration of peroxide for treating or preventing vaginal infections
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
PL373528A1 (en) Medicine for preventing and treating bromidrosis
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE321568T1 (de) Impfkomplex zur vorbeugung und behandlung von leishmaniasis
PL377110A1 (pl) Zapobieganie i leczenie choroby Alzheimera
GB0221446D0 (en) Treatment of infection in animals
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE60043936D1 (de) Vorbeugung und behandlung von p. gingivalis infektion
EP1225912A4 (en) PROPHYLAXIS AND TREATMENT PROCESS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.